JP2023531872A5 - - Google Patents
Info
- Publication number
- JP2023531872A5 JP2023531872A5 JP2022573664A JP2022573664A JP2023531872A5 JP 2023531872 A5 JP2023531872 A5 JP 2023531872A5 JP 2022573664 A JP2022573664 A JP 2022573664A JP 2022573664 A JP2022573664 A JP 2022573664A JP 2023531872 A5 JP2023531872 A5 JP 2023531872A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acids
- free amino
- therapeutically effective
- combination
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032185P | 2020-05-29 | 2020-05-29 | |
| US63/032,185 | 2020-05-29 | ||
| US202063080470P | 2020-09-18 | 2020-09-18 | |
| US63/080,470 | 2020-09-18 | ||
| US202063088813P | 2020-10-07 | 2020-10-07 | |
| US63/088,813 | 2020-10-07 | ||
| US202163136404P | 2021-01-12 | 2021-01-12 | |
| US63/136,404 | 2021-01-12 | ||
| PCT/US2021/034807 WO2021243183A1 (en) | 2020-05-29 | 2021-05-28 | Formulations and methods for treating acute respiratory distress syndrome, asthma, or allergic rhinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531872A JP2023531872A (ja) | 2023-07-26 |
| JP2023531872A5 true JP2023531872A5 (https=) | 2024-08-09 |
Family
ID=78722883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573664A Pending JP2023531872A (ja) | 2020-05-29 | 2021-05-28 | 急性呼吸窮迫症候群、喘息、又はアレルギー性鼻炎を治療するための製剤及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230201151A1 (https=) |
| EP (1) | EP4157218A4 (https=) |
| JP (1) | JP2023531872A (https=) |
| KR (1) | KR20230018474A (https=) |
| CN (1) | CN115697301A (https=) |
| AU (1) | AU2021280328A1 (https=) |
| BR (1) | BR112022024033A2 (https=) |
| CA (1) | CA3177780A1 (https=) |
| MX (1) | MX2022015044A (https=) |
| WO (1) | WO2021243183A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116036277B (zh) * | 2022-07-19 | 2023-10-31 | 广州国家实验室 | 氯离子在预防、治疗冠状病毒所致疾病中的应用 |
| US11878073B1 (en) | 2022-09-20 | 2024-01-23 | Entrinsic, LLC | Generation of hydration-targeted formulations and methods of use therein |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6686340B2 (en) * | 2001-06-19 | 2004-02-03 | Matthias Rath | Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells |
| CN104207146A (zh) * | 2014-07-26 | 2014-12-17 | 胡安然 | 呼吸系统疾病全营养配方食品 |
| EP3691628A1 (en) * | 2017-10-02 | 2020-08-12 | University of Florida Research Foundation, Incorporated | Materials and methods for inhibiting tumor growth |
| WO2019070759A1 (en) * | 2017-10-02 | 2019-04-11 | University Of Florida Research Foundation Incorporated | AMINO ACID COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS |
| CA3116015A1 (en) * | 2018-10-30 | 2020-05-07 | University Of Florida Research Foundation, Incorporated | Amino acid compositions and methods for treating cystic fibrosis |
-
2021
- 2021-05-28 CA CA3177780A patent/CA3177780A1/en active Pending
- 2021-05-28 CN CN202180038692.7A patent/CN115697301A/zh active Pending
- 2021-05-28 EP EP21812111.9A patent/EP4157218A4/en active Pending
- 2021-05-28 US US18/000,177 patent/US20230201151A1/en active Pending
- 2021-05-28 BR BR112022024033A patent/BR112022024033A2/pt not_active Application Discontinuation
- 2021-05-28 WO PCT/US2021/034807 patent/WO2021243183A1/en not_active Ceased
- 2021-05-28 AU AU2021280328A patent/AU2021280328A1/en active Pending
- 2021-05-28 MX MX2022015044A patent/MX2022015044A/es unknown
- 2021-05-28 KR KR1020227046211A patent/KR20230018474A/ko active Pending
- 2021-05-28 JP JP2022573664A patent/JP2023531872A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240245690A1 (en) | Treatment of Respiratory Diseases | |
| US20170182088A1 (en) | Method and apparatus for administering nitric oxide with supplemental drugs | |
| US8709496B2 (en) | Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract | |
| JP2012500091A5 (https=) | ||
| JP2019530750A5 (https=) | ||
| JP2023531872A5 (https=) | ||
| US20100261690A1 (en) | Novel combinations | |
| CN103200955A (zh) | 包含肽和病毒神经氨酸酶抑制剂的组合物 | |
| JP2023503380A (ja) | ペプチド及び炎症の治療におけるそれらの使用 | |
| US11433080B2 (en) | Antiviral treatment | |
| CN111803635A (zh) | 小分子抑制剂在治疗呼吸道病毒性肺炎上的应用 | |
| CN108926707A (zh) | Pf4的抗rsv应用 | |
| ES3002532T3 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| CN105326789B (zh) | 氨溴索沙丁胺醇溶液剂 | |
| US20250073190A1 (en) | Compositions and Use of N-Chlorotaurine for Treatment and Prevention of Respiratory Infections | |
| CN102369012B (zh) | 氧化氘用于治疗病毒性呼吸道疾病的用途 | |
| HK40029346B (en) | Use of a small molecule inhibitor for treatment of respiratory viral pneumonia | |
| EA048350B1 (ru) | Применение даларгина для профилактики орви и предотвращения развития осложнений при заболеваниях орви | |
| AR128201A1 (es) | USO DE ÓXIDO NÍTRICO INHALADO (iNO) PARA TRATAR PACIENTES CON HIPERTENSIÓN PULMONAR ASOCIADA CON SARCOIDOSIS (PH-SARC) | |
| CN103690934B (zh) | 干扰素α与布地奈德的雾化吸入剂 | |
| CN102430112A (zh) | 干扰素α与硫酸沙丁胺醇的雾化吸入剂 | |
| CN105326790B (zh) | 氨溴索沙丁胺醇溶液剂的制备方法 | |
| EA044475B1 (ru) | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний | |
| IT202000014350A1 (it) | NUOVO APPROCCIO FARMACOLOGICO PER IL TRATTAMENTO DI SARS-CoV2 E VIRUS INFLUENZALI TRAMITE L’USO DI SPRAY NASALI | |
| CN115461356A (zh) | 用于预防或治疗covid-19的肽 |